Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Baird analyst Andrew Wittmann downgraded the rating for Parsons Corporation PSN from Outperform to Neutral and lowered the price target from $72 to $69. Parsons shares closed at $66.86 on Wednesday. See how other analysts view this stock.
- Wells Fargo analyst Larry Biegelsen downgraded Glaukos Corporation GKOS from Overweight to Equal-Weight and lowered the price target from $160 to $86. Glaukos shares closed at $94.25 on Wednesday. See how other analysts view this stock.
- Wells Fargo analyst Yanan Zhu downgraded the rating for Regulus Therapeutics Inc. RGLS from Overweight to Equal-Weight and announced a $9 price target. Regulus Therapeutics shares closed at $7.98 on Wednesday. See how other analysts view this stock.
Considering buying PSN stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
